Clinical Trials Browser

Completed × Hematologic Neoplasms × tocilizumab × Clear all

NCT03699631 2023-04-19

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

Phase 2 Completed

29 enrolled 9 charts

Other hematologic neoplasm

Hematologic Neoplasms